HNN3.0

Project cooperationUpdated on 22 January 2026

Saliva-based metabolomics platform & expertise for Horizon research and innovation projects

cofounder/CSO at Maven Health

Zurich, Switzerland

About

We are an EPFL spin-off developing a scalable, non-invasive metabolomics platform based on saliva analysis using nuclear magnetic resonance (NMR) spectroscopy combined with automated data processing and interpretation algorithms.

Our technology enables robust quantification of a broad panel of metabolites from saliva with minimal sample preparation, making it well suited for preventive health, longitudinal monitoring, and population-level studies. Beyond the analytical layer, we provide a secure digital platform that transforms complex metabolomic data into interpretable, action-oriented insights for professional use.

We are interested in project cooperation within Horizon Europe and related programmes, and can contribute as a technology provider, scientific partner, or application partner. We are particularly interested in collaborations involving:

  • Preventive and personalised healthcare

  • Metabolic health, nutrition, and lifestyle interventions

  • Non-invasive diagnostics and monitoring

  • Digital health platforms and data-driven health insights

  • Validation of novel biomarkers and real-world pilot studies

What we offer to a consortium:

  • Proprietary saliva-based metabolomics technology (NMR-based)

  • Expertise in saliva analytics, metabolomics, and biomarker interpretation

  • Automated data processing and scalable platform infrastructure

  • Experience with human studies and real-world validation

  • An asset-light laboratory model leveraging established NMR partners

We are open to joining existing consortia or co-developing new project proposals where non-invasive metabolic profiling and actionable health insights can add scientific, clinical, or societal value.

Topic

  • DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-02: Behavioural interventions as primary prevention for Non-Communicable Diseases (NCDs) among young people
  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)
  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
  • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches
  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices

Organisation

Maven Health

Start-up

Zurich, Switzerland

Similar opportunities